Funding round brings in $15M for Pa. biotech

05/6/2013 | American City Business Journals

AltheRx Pharmaceuticals secured $15 million in its latest funding round. The Exton, Pa.-based firm plans to use the money to bring Solabegron, its lead drug candidate for overactive bladder, into late-stage trials. AltheRx also appointed Jim Bennethum, former executive vice president of Becker Ventures, as its new CEO.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI